Thyrotropin receptor-stimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways.
暂无分享,去创建一个
E. Fliers | W. Wiersinga | M. D. de Gooyer | C. V. van Zeijl | A. Boelen | O. Surovtseva | C. V. van Koppen | M. Mourits | A. Miltenburg
[1] E. Fliers,et al. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients. , 2010, Thyroid : official journal of the American Thyroid Association.
[2] M. Schott. A Stimulatory Thyrotropin Receptor Antibody (M22) and Thyrotropin Increase Interleukin-6 Expression and Secretion in Graves' Orbital Preadipocyte Fibroblasts , 2010 .
[3] R. Bahn. Graves' ophthalmopathy. , 2010, The New England journal of medicine.
[4] S. Rauz,et al. The role of 11beta-hydroxysteroid dehydrogenase 1 in adipogenesis in thyroid-associated ophthalmopathy. , 2010, The Journal of clinical endocrinology and metabolism.
[5] M. Ludgate,et al. Thyrotropin Receptor Activation Increases Hyaluronan Production in Preadipocyte Fibroblasts , 2009, The Journal of Biological Chemistry.
[6] R. Latif,et al. Characterization of thyrotropin receptor antibody-induced signaling cascades. , 2009, Endocrinology.
[7] Terry J. Smith,et al. Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy. , 2008, Thyroid : official journal of the American Thyroid Association.
[8] Jan Kelder,et al. A signaling-selective, nanomolar potent allosteric low molecular weight agonist for the human luteinizing hormone receptor , 2008, Naunyn-Schmiedeberg's Archives of Pharmacology.
[9] S. Feldon,et al. Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes. , 2006, The American journal of pathology.
[10] N. Morgenthaler,et al. Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. , 2006, The Journal of clinical endocrinology and metabolism.
[11] C. Marcocci,et al. Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation. , 2005, European journal of endocrinology.
[12] M. Mummert. Immunologic roles of hyaluronan , 2005, Immunologic research.
[13] Terry J. Smith,et al. Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor. , 2004, The Journal of clinical endocrinology and metabolism.
[14] M. Ludgate,et al. Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo. , 2003, Journal of molecular endocrinology.
[15] W. Wiersinga,et al. TSH‐R expression and cytokine profile in orbital tissue of active vs. inactive Graves’ ophthalmopathy patients , 2003, Clinical endocrinology.
[16] R. Bahn,et al. Stimulation of adipogenesis, peroxisome proliferator-activated receptor-γ (PPARγ), and thyrotropin receptor by PPARγ agonist in human orbital preadipocyte fibroblasts , 2002 .
[17] R. Bahn,et al. Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts. , 2002, The Journal of clinical endocrinology and metabolism.
[18] M. Crisp,et al. Adipogenesis in thyroid eye disease. , 2000, Investigative ophthalmology & visual science.
[19] A. Sorisky,et al. Functional TSH receptor in human abdominal preadipocytes and orbital fibroblasts. , 2000, American journal of physiology. Cell physiology.
[20] P. Heldin,et al. Expression of human hyaluronan synthases in response to external stimuli. , 2000, The Biochemical journal.
[21] M. Gerding,et al. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy , 2000, Clinical endocrinology.
[22] A. Weetman,et al. Graves' disease , 1988 .
[23] T. Smith,et al. Expression of hyaluronan synthase messenger ribonucleic acids and their induction by interleukin-1beta in human orbital fibroblasts: potential insight into the molecular pathogenesis of thyroid-associated ophthalmopathy. , 1999, The Journal of clinical endocrinology and metabolism.
[24] S. Jyonouchi,et al. Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor. , 1999, The Journal of clinical endocrinology and metabolism.
[25] B. Rapoport,et al. The Thyrotropin (TSH)-Releasing Hormone Receptor: Interaction with TSH and Autoantibodies , 1998 .
[26] Terry J. Smith,et al. Activation of Human Orbital Fibroblasts through CD40 Engagement Results in a Dramatic Induction of Hyaluronan Synthesis and Prostaglandin Endoperoxide H Synthase-2 Expression , 1998, The Journal of Biological Chemistry.
[27] B. Rapoport,et al. The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. , 1998, Endocrine reviews.
[28] Terry J. Smith,et al. Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. , 1997, The American journal of pathology.
[29] W. Wiersinga,et al. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy , 1997, Clinical endocrinology.
[30] A. Sorisky,et al. Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture. , 1996, The Journal of clinical endocrinology and metabolism.
[31] T. Smith,et al. Leukoregulin is a potent inducer of hyaluronan synthesis in cultured human orbital fibroblasts. , 1995, The American journal of physiology.
[32] Y. Shishiba,et al. Effects of dibutyryl cyclic AMP on hyaluronan and proteoglycan synthesis by retroocular tissue fibroblasts in culture. , 1994, Endocrine journal.
[33] C. Gorman,et al. Stimulation of glycosaminoglycan accumulation by interferon gamma in cultured human retroocular fibroblasts. , 1991, The Journal of clinical endocrinology and metabolism.
[34] G. Woloschak,et al. Human retroocular fibroblasts in vitro: a model for the study of Graves' ophthalmopathy. , 1987, The Journal of clinical endocrinology and metabolism.
[35] M. Namba,et al. Hyaluronate synthetase inhibition by normal and transformed human fibroblasts during growth reduction , 1987, The Journal of cell biology.
[36] J. Hopwood,et al. Absence of hyaluronidase in cultured human skin fibroblasts. , 1975, Biochemical and biophysical research communications.
[37] R. Tobey,et al. CELL-CYCLE DEPENDENT DESQUAMATION OF HEPARAN SULFATE FROM THE CELL SURFACE , 1972, The Journal of cell biology.